Inspire Medical Systems ROA 2017-2025 | INSP
Current and historical return on assets (ROA) values for Inspire Medical Systems (INSP) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Inspire Medical Systems ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-03-31 | $0.07B | $0.73B | 8.62% |
| 2024-12-31 | $0.05B | $0.81B | 7.02% |
| 2024-09-30 | $0.03B | $0.80B | 4.57% |
| 2024-06-30 | $0.01B | $0.73B | 0.88% |
| 2024-03-31 | $-0.02B | $0.69B | -2.44% |
| 2023-12-31 | $-0.02B | $0.68B | -3.35% |
| 2023-09-30 | $-0.03B | $0.64B | -5.51% |
| 2023-06-30 | $-0.04B | $0.62B | -7.18% |
| 2023-03-31 | $-0.04B | $0.57B | -8.79% |
| 2022-12-31 | $-0.05B | $0.57B | -10.75% |
| 2022-09-30 | $-0.05B | $0.53B | -14.23% |
| 2022-06-30 | $-0.04B | $0.29B | -14.88% |
| 2022-03-31 | $-0.04B | $0.29B | -14.79% |
| 2021-12-31 | $-0.04B | $0.30B | -14.66% |
| 2021-09-30 | $-0.05B | $0.28B | -16.65% |
| 2021-06-30 | $-0.05B | $0.27B | -16.76% |
| 2021-03-31 | $-0.06B | $0.27B | -20.42% |
| 2020-12-31 | $-0.06B | $0.28B | -22.63% |
| 2020-09-30 | $-0.06B | $0.27B | -26.07% |
| 2020-06-30 | $-0.06B | $0.27B | -27.97% |
| 2020-03-31 | $-0.04B | $0.17B | -22.91% |
| 2019-12-31 | $-0.03B | $0.18B | -17.84% |
| 2019-09-30 | $-0.03B | $0.18B | -15.28% |
| 2019-06-30 | $-0.03B | $0.19B | -14.71% |
| 2019-03-31 | $-0.02B | $0.19B | -14.66% |
| 2018-12-31 | $-0.02B | $0.20B | -18.66% |
| 2018-09-30 | $-0.02B | $0.13B | -27.67% |
| 2018-06-30 | $-0.02B | $0.13B | -44.92% |
| 2018-03-31 | $-0.02B | $0.03B | -150.94% |
| 2017-12-31 | $-0.02B | $0.03B | -272.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $3.751B | $0.803B |
| Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.172B | 58.74 |
| Hims & Hers Health (HIMS) | United States | $12.418B | 129.02 |
| Tempus AI (TEM) | United States | $12.340B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.592B | 0.00 |
| Privia Health (PRVA) | United States | $2.761B | 188.75 |
| Hinge Health (HNGE) | United States | $2.719B | 0.00 |
| Enovis (ENOV) | United States | $1.822B | 10.16 |
| Schrodinger (SDGR) | United States | $1.572B | 0.00 |
| Phreesia (PHR) | United States | $1.547B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.468B | 0.00 |
| Azenta (AZTA) | United States | $1.401B | 65.11 |
| Omnicell (OMCL) | United States | $1.370B | 24.17 |
| 10x Genomics (TXG) | United States | $1.282B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.630B | 0.00 |
| Claritev (CTEV) | United States | $0.610B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.569B | 0.00 |
| Veradigm (MDRX) | United States | $0.487B | 0.00 |
| Talkspace (TALK) | United States | $0.477B | 142.50 |
| Standard BioTools (LAB) | United States | $0.399B | 0.00 |
| Outset Medical (OM) | United States | $0.354B | 0.00 |
| TruBridge (TBRG) | United States | $0.347B | 769.00 |
| Health Catalyst (HCAT) | United States | $0.264B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.257B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.191B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.149B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.138B | 0.00 |
| Pulmonx (LUNG) | United States | $0.122B | 0.00 |
| American Well (AMWL) | United States | $0.106B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.095B | 0.00 |
| CareCloud (CCLD) | United States | $0.088B | 3.34 |
| 111 (YI) | China | $0.070B | 0.00 |
| HeartBeam (BEAT) | United States | $0.051B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.048B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.033B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.032B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.022B | 0.00 |
| Precipio (PRPO) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.001B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |